发明公开
EP0583579A3 New 17-hydroxyiminomethyl-5beta, 14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
失效
新的17羟基亚5beta，14beta-雄甾烷衍生物，kardioaktives它们的制备和它们的药物制剂的过程。
- 专利标题： New 17-hydroxyiminomethyl-5beta, 14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
- 专利标题（中）： 新的17羟基亚5beta，14beta-雄甾烷衍生物，kardioaktives它们的制备和它们的药物制剂的过程。
-
申请号： EP93110189.3申请日： 1993-06-25
-
公开(公告)号： EP0583579A3公开(公告)日： 1995-03-22
- 发明人: Cerri, Alberto , Bernardi, Luigi , Bianchi, Giuseppe , Florio, Monica , Folpini, Elena , Melloni, Piero
- 申请人： Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- 申请人地址： Viale Shakespeare, 47 I-00144 Roma IT
- 专利权人： Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- 当前专利权人： Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
- 当前专利权人地址： Viale Shakespeare, 47 I-00144 Roma IT
- 代理机构： Fassi, Aldo
- 优先权： DE4227605 19920820
- 主分类号： C07J41/00
- IPC分类号： C07J41/00 ; C07J43/00 ; A61K31/56 ; A61K31/57 ; A61K31/58
摘要：
17-Hydroxyiminomethyl-14β-hydroxy-5β-androstane derivatives of general formula I
wherein the symbol , the symbol , R 1 , R 2 , R 3 and Y have the meaning as indicated in the specification as well as their stereoisomers, Z and E isomers, tautomers, optical isomers and mixtures thereof and their pharmaceutically acceptable salts. Processes for their preparation, pharmaceutical compositions and uses for the making of a medicament containing them are also disclosed.
wherein the symbol , the symbol , R 1 , R 2 , R 3 and Y have the meaning as indicated in the specification as well as their stereoisomers, Z and E isomers, tautomers, optical isomers and mixtures thereof and their pharmaceutically acceptable salts. Processes for their preparation, pharmaceutical compositions and uses for the making of a medicament containing them are also disclosed.
公开/授权文献
信息查询
